{"id":"9cd22024-47a5-5fb7-b272-4ad9c2b8576c","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-ser530-binds-other-drugs","predicate":"binds","statement":"Diclofenac inhibition was unaffected by mutation of Arg-120 to alanine but was dramatically attenuated by the S530A mutation, and the crystal structure of diclofenac with murine COX-2 shows it bound in an inverted conformation with its carboxylate hydrogen-bonded to Tyr-385 and Ser-530, the first experimental demonstration that an acidic non-steroidal anti-inflammatory drug can bind in an orientation that precludes a salt bridge with Arg-120; Ser-530 is also important in time-dependent inhibition by nimesulide and piroxicam.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"020fd95f-d058-5167-b6eb-c1c47503b2a5","mechanism_event_label":"The same serine aspirin attacks is where several other anti-inflammatories anchor themselves.","subject":{"id":"7a465c55-930d-54cf-89b3-952b2c16f558","slug":"cox1-ser530","display_name":"Serine 530 of cyclooxygenase-1","entity_type_key":"protein_state"},"object":{"id":"2d3faead-6df2-5e17-ad25-6f7c20a2ae05","slug":"diclofenac","display_name":"Diclofenac","entity_type_key":"drug"},"evidence_count":1,"mechanism_event":{"id":"020fd95f-d058-5167-b6eb-c1c47503b2a5","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-ser530-binds-other-drugs-event","event_type":"observed_intervention","label":"The same serine aspirin attacks is where several other anti-inflammatories anchor themselves.","description":"Diclofenac inhibition was unaffected by mutation of Arg-120 to alanine but was dramatically attenuated by the S530A mutation, and the crystal structure of diclofenac with murine COX-2 shows it bound in an inverted conformation with its carboxylate hydrogen-bonded to Tyr-385 and Ser-530, the first experimental demonstration that an acidic non-steroidal anti-inflammatory drug can bind in an orientation that precludes a salt bridge with Arg-120; Ser-530 is also important in time-dependent inhibition by nimesulide and piroxicam.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"c8a31ed4-f2ca-5d43-8352-e9935129a785","slug":"ptgs2","display_name":"Cyclooxygenase-2 (PTGS2)","entity_type_key":"protein"},"role":"host_enzyme","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"b677bbcf-dff6-53ad-b217-1274bea2e43f","slug":"cox-active-site-channel","display_name":"The hydrophobic substrate channel of the cyclooxygenase active site","entity_type_key":"protein_state"},"role":"binding_region","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"7a465c55-930d-54cf-89b3-952b2c16f558","slug":"cox1-ser530","display_name":"Serine 530 of cyclooxygenase-1","entity_type_key":"protein_state"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"2d3faead-6df2-5e17-ad25-6f7c20a2ae05","slug":"diclofenac","display_name":"Diclofenac","entity_type_key":"drug"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/aspirin-research/12925531.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"732e941e7f912ae2495715634eabdef176dae39e32359609f15b05a230d5f6e0\", \"start_char\": 0, \"end_char\": 1473, \"text_sha256\": \"732e941e7f912ae2495715634eabdef176dae39e32359609f15b05a230d5f6e0\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Site-directed mutants of COX-2 at Arg-120, Tyr-355, Tyr-348 and Ser-530 tested against a series of inhibitors, with a diclofenac co-crystal structure","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Diclofenac, nimesulide and piroxicam against the mutant panel","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Shows the acetylation serine is also a general binding determinant for other drugs. The structural work is on murine rather than human enzyme.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.","comparator":null,"unit":null,"notes":"","entity":{"slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Mouse enzyme","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The same serine aspirin attacks is where several other anti-inflammatories anchor themselves.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[asa-p12925531] A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385. (2003). https://pubmed.ncbi.nlm.nih.gov/12925531/ DOI: 10.1074/jbc.m305481200","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Cyclooxygenase-2","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"4f40ac60-8bbb-5939-bea3-b149561d9cb8","evidence_kind":"source_excerpt","locator":"Lines 169-180","start_line":169,"end_line":180,"excerpt":"### asa-ser530-binds-other-drugs\nDiclofenac inhibition was unaffected by mutation of Arg-120 to alanine but was dramatically attenuated by the S530A mutation, and the crystal structure of diclofenac with murine COX-2 shows it bound in an inverted conformation with its carboxylate hydrogen-bonded to Tyr-385 and Ser-530, the first experimental demonstration that an acidic non-steroidal anti-inflammatory drug can bind in an orientation that precludes a salt bridge with Arg-120; Ser-530 is also important in time-dependent inhibition by nimesulide and piroxicam.\nCondition category: normal\nnutrient_topic: Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.\nplain_language: The same serine aspirin attacks is where several other anti-inflammatories anchor themselves.\norganism: Mouse enzyme\ntissue_or_cell_type: Cyclooxygenase-2\nexperimental_model: Site-directed mutants of COX-2 at Arg-120, Tyr-355, Tyr-348 and Ser-530 tested against a series of inhibitors, with a diclofenac co-crystal structure\nlimitations: Shows the acetylation serine is also a general binding determinant for other drugs. The structural work is on murine rather than human enzyme.\nexposure: Diclofenac, nimesulide and piroxicam against the mutant panel\nevidence_span: {\"source_cache\": \"artifacts/aspirin-research/12925531.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"732e941e7f912ae2495715634eabdef176dae39e32359609f15b05a230d5f6e0\", \"start_char\": 0, \"end_char\": 1473, \"text_sha256\": \"732e941e7f912ae2495715634eabdef176dae39e32359609f15b05a230d5f6e0\"}\n[asa-p12925531] A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385. (2003). https://pubmed.ncbi.nlm.nih.gov/12925531/ DOI: 10.1074/jbc.m305481200","model_system":"Site-directed mutants of COX-2 at Arg-120, Tyr-355, Tyr-348 and Ser-530 tested against a series of inhibitors, with a diclofenac co-crystal structure","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [asa-p12925531] A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385. (2003). https://pubmed.ncbi.nlm.nih.gov/12925531/ DOI: 10.1074/jbc.m305481200","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"712cf519-cd27-5a8b-9e2f-961a98d7a27e","stable_key":"import-f8641d02-8413-5bd8-92e9-62ad49286e81","title":"Aspirin: the serine it acetylates, the enzyme that acetylation creates, the dose that separates platelet from vessel wall, and the metabolite that is a different drug (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"93dd4343051c131e40d4fc3c95a978cd65478c13dcdb3f2d42507c49b09cb647","revision_id":"694e8ee7-49ca-5e6c-b58b-8ba8f82c2ad8","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}